Intercure Ltd (INCR) Directors and Executive Officers - CSIMarket
CSIMarket
 
Intercure Ltd   (NASDAQ: INCR)

Intercure Ltd

Officers & Directors


Alexander Rabinovich, age 55, is the Chairman of the Board and Chief Executive Officer of InterCure. He has been a board member since October 2018 and Chairman since February 2025. Rabinovich has experience with Nasdaq and TASE listed companies and holds a B.A. in economics and accounting from the University of Haifa, Israel. David Salton, age 66, has served as an independent director of InterCure since December 2014. He has over 26 years of management experience in investment banking and life science startups and has been CEO of AnchorMesh Ltd. since July 2024. Lennie Michelson Grinbaum, age 50, and Gideon Hirschfeld, age 60, serve as External Directors. Alon Granot, age 64, has been a director of InterCure since November 2020 and a board member of Canndoc since February 2019. He was CEO of Canndoc from September 2019 to December 2020 and has held various executive and director roles in other companies. Granot holds a B.A. from Haifa University and an M.A. from Technion-Israel Institute of Technology. Amos Cohen, age 46, has been Chief Financial Officer since February 2020. He has over 18 years of financial experience, including serving as CFO of Trendline Information and Communication Services Ltd. Cohen holds a B.A. in economics from Ben-Gurion University and an M.A. in accounting from the College of Management Academic Studies, Israel.

Intercure Ltd currently has 450 employees.

  News about Intercure Ltd Key Personnel

InterCure Overcomes Challenges, Provides Update on Nir Oz Facility Amidst Security Situation in Israel


InterCure Provides an Update Regarding Nir Oz Facility
InterCure, the leading medical cannabis company in Israel and outside of North America, has released an update regarding the status of its facility in Kibbutz Nir Oz, also known as the Southern Israel Site. This update comes in response to the security situation in Israel and its impact on the company and its employees.
In October 2023, InterCure provided an initial update on the security situation. Now, the company provides further information on the status of its facility. Despite the challenges posed by the security situation, InterCure remains committed to ensuring the safety of its employees and the successful operation of its operation...






INCR Management Effectiveness INCR Revenue per Employee INCR Income per Employee


Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.